Status:
UNKNOWN
Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized Patients
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
ANCA-related Vasculitis
Eligibility:
All Genders
Brief Summary
Laboratory testing of Anti-Neutrophil Cytoplasm Antibody (ANCA) is used to confirm diagnosis of patients who have a high level of suspicion for ANCA-related vasculitis. In these patients the specifici...
Eligibility Criteria
Inclusion
- Blood samples sent for ANCA lab test
Exclusion
- Patients with ANCA vasculitis
- Patients with known malignancy
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT01238003
Start Date
December 1 2010
End Date
December 1 2011
Last Update
November 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe MC,
Hadera, Israel